November 22, 2016 - By Clifton Ray · 0 Comments
The stock of Zoetis Incorporated (NYSE:ZTS) registered a decrease of 8.08% in short interest. ZTS’s total short interest was 7.61 million shares in November as published by FINRA. Its down 8.08% from 8.28 million shares, reported previously. With 3.78M shares average volume, it will take short sellers 2 days to cover their ZTS’s short positions. The short interest to Zoetis Incorporated’s float is 1.54%. About 58,846 shares traded hands. Zoetis Inc (NYSE:ZTS) has risen 3.16% since April 20, 2016 and is uptrending. It has underperformed by 1.40% the S&P500.
Zoetis Inc. is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The company has a market cap of $24.64 billion. The Firm has a diversified business, marketing products across over eight core species: cattle, swine, poultry, sheep and fish , and dogs, cats and horses (collectively, companion animals), and within over five product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals. It has a 36.03 P/E ratio. It operates through two divisions: the United States and International.
Insitutional Activity: The institutional sentiment increased to 1.19 in 2016 Q2. Its up 0.11, from 1.08 in 2016Q1. The ratio increased, as 48 funds sold all Zoetis Inc shares owned while 212 reduced positions. 72 funds bought stakes while 210 increased positions. They now own 451.82 million shares or 1.32% less from 457.84 million shares in 2016Q1.
Pdts Partners holds 144,600 shares or 0.54% of its portfolio. Intl Inc holds 0% of its portfolio in Zoetis Inc (NYSE:ZTS) for 228,865 shares. Aperio Gru Lc last reported 0.06% of its portfolio in the stock. Allsquare Wealth Mngmt Ltd holds 478 shares or 0.02% of its portfolio. Palisade Ltd Nj last reported 0.33% of its portfolio in the stock. Deere has 0.06% invested in the company for 22,324 shares. Mitsubishi Ufj Securities holds 0.07% of its portfolio in Zoetis Inc (NYSE:ZTS) for 810 shares. Mutual Of America Cap Mgmt Ltd Limited Liability Company last reported 60,071 shares in the company. Blackrock Fund Advsrs accumulated 8.10M shares or 0.08% of the stock. Teachers Advsrs Inc last reported 1.92M shares in the company. Fdx Advsrs has 0.03% invested in the company for 13,032 shares. Independent Consultants, a Florida-based fund reported 12,258 shares. Winslow Mgmt Lc last reported 10.55M shares in the company. The California-based Wells Fargo & Mn has invested 0.09% in Zoetis Inc (NYSE:ZTS). Rothschild Asset reported 13,996 shares or 0.01% of all its holdings.
Insider Transactions: Since September 1, 2016, the stock had 1 buy, and 3 insider sales for $2.74 million net activity. On Tuesday, September 6 MCCALLISTER MICHAEL B bought $102,680 worth of the stock or 2,000 shares. Another trade for 9,797 shares valued at $494,063 was made by Lagano Roxanne on Tuesday, November 8. $1.64 million worth of Zoetis Inc (NYSE:ZTS) was sold by Chen Heidi C.. 13,870 shares with value of $710,838 were sold by Fenton Andrew on Friday, September 2.
Out of 11 analysts covering Zoetis Inc (NYSE:ZTS), 8 rate it a “Buy”, 1 “Sell”, while 2 “Hold”. This means 73% are positive. Zoetis Inc has been the topic of 20 analyst reports since July 24, 2015 according to StockzIntelligence Inc. The company was initiated on Wednesday, June 1 by Stifel Nicolaus. Credit Suisse initiated the shares of ZTS in a report on Thursday, February 4 with “Outperform” rating. The stock of Zoetis Inc (NYSE:ZTS) earned “Buy” rating by Bank of America on Thursday, September 29. Citigroup maintained Zoetis Inc (NYSE:ZTS) rating on Thursday, August 4. Citigroup has “Neutral” rating and $53 price target. Goldman Sachs downgraded Zoetis Inc (NYSE:ZTS) on Friday, May 6 to “Sell” rating. The firm has “Buy” rating by Zacks given on Thursday, September 17. The firm has “Buy” rating by Jefferies given on Tuesday, June 14. The stock has “Outperform” rating given by BMO Capital Markets on Friday, September 11. The company was maintained on Tuesday, March 15 by Jefferies. The company was upgraded on Thursday, August 6 by William Blair.
Zoetis Inc., incorporated on July 25, 2012, is engaged in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. The Firm has a diversified business, marketing products across over eight core species: cattle, swine, poultry, sheep and fish (collectively, livestock), and dogs, cats and horses (collectively, companion animals), and within over five product categories: anti-infectives, vaccines, parasiticides, medicated feed additives and other pharmaceuticals. The Firm operates through two divisions: the United States and International. Within each of these divisions, the Company offers a diversified product portfolio for both livestock and companion animal customers. In addition, its Client Supply Services (CSS) organization provides contract manufacturing services to third parties.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
By Clifton Ray